Company profile · Sponsor
Tenaya
Tenaya Therapeutics
- Pipeline
- 2
- Drugs
- 0
- Patents
- 8
Quick answer
Tenaya (TNYA) is a biotech company. headquartered in SOUTH SAN FRANCISCO, CA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 8 patents to this profile..
Company facts
Pipeline (2)
Search pipeline →Patents (8)
Search patents →-
US 12312345
Fluoroalkyl-oxadiazoles and uses thereof
granted -
US 12201617
HDAC6 inhibitors for treatment of metabolic disease and HFpEF
granted -
US 12168778
Cardiac cell reprogramming with myocardin and ASCL1
granted -
US 12151001
Optimized expression cassettes for gene therapy
granted -
US 12104165
Adeno-associated virus with engineered capsid
granted -
US 11926622
Fluoroalkyl-oxadiazoles and uses thereof
granted -
US 11913012
Cardiac cell reprogramming with myocardin and ASCL1
granted -
US 11781156
Plakophillin-2 gene therapy methods and compositions
granted
Frequently asked questions
What is Tenaya?
Tenaya (TNYA) is a biotech company. headquartered in SOUTH SAN FRANCISCO, CA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 8 patents to this profile..
What pipeline programs does Tenaya sponsor?
We track 2 ClinicalTrials.gov-linked programs for Tenaya, including TN-201 and 1 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does Tenaya company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.